TARA logo

Protara Therapeutics (TARA) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$162.80 M
+$123.21 M+311.25%

December 31, 2024


Summary


Performance

TARA Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTARAbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$162.80 M
+$111.04 M+214.54%

December 1, 2024


Summary


Performance

TARA Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTARAbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

TARA Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+311.3%+311.3%
3 y3 years+355.7%+382.1%
5 y5 years+10000.0%+382.1%

TARA Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+574.8%at high+673.9%
5 y5-year-3.4%>+9999.0%-3.4%>+9999.0%
alltimeall time-3.4%>+9999.0%-3.4%>+9999.0%

Protara Therapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
$162.80 M(+311.3%)
-
Dec 2024
-
$162.80 M(+214.5%)
Sep 2024
-
$51.76 M(-42.2%)
Jun 2024
-
$89.58 M(+71.5%)
Mar 2024
-
$52.23 M(+31.9%)
Dec 2023
$39.59 M(+64.1%)
$39.59 M(+17.2%)
Sep 2023
-
$33.77 M(-0.6%)
Jun 2023
-
$33.98 M(+61.5%)
Mar 2023
-
$21.04 M(-12.8%)
Dec 2022
$24.13 M
$24.13 M(-49.2%)
Sep 2022
-
$47.50 M(+40.5%)
Jun 2022
-
$33.81 M(+32.9%)
DateAnnualQuarterly
Mar 2022
-
$25.44 M(-28.8%)
Dec 2021
$35.72 M(-78.8%)
$35.72 M(-12.3%)
Sep 2021
-
$40.74 M(-13.0%)
Jun 2021
-
$46.84 M(-19.5%)
Mar 2021
-
$58.20 M(-65.5%)
Dec 2020
$168.60 M(>+9900.0%)
$168.60 M(+1.6%)
Sep 2020
-
$165.90 M(+453.6%)
Jun 2020
-
$29.97 M(-16.9%)
Mar 2020
-
$36.07 M(+6295.2%)
Dec 2019
$564.00 K(-97.1%)
$564.00 K(-98.7%)
Sep 2019
-
$41.86 M
Dec 2018
$19.37 M
-

FAQ

  • What is Protara Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Protara Therapeutics?
  • What is Protara Therapeutics annual cash & cash equivalents year-on-year change?
  • What is Protara Therapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Protara Therapeutics?
  • What is Protara Therapeutics quarterly cash and cash equivalents year-on-year change?

What is Protara Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of TARA is $162.80 M

What is the all time high annual cash & cash equivalents for Protara Therapeutics?

Protara Therapeutics all-time high annual cash & cash equivalents is $168.60 M

What is Protara Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, TARA annual cash & cash equivalents has changed by +$123.21 M (+311.25%)

What is Protara Therapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of TARA is $162.80 M

What is the all time high quarterly cash and cash equivalents for Protara Therapeutics?

Protara Therapeutics all-time high quarterly cash and cash equivalents is $168.60 M

What is Protara Therapeutics quarterly cash and cash equivalents year-on-year change?

Over the past year, TARA quarterly cash and cash equivalents has changed by +$123.21 M (+311.25%)